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Abstract
Bone marrow-derived mesenchymal stem cells (MSC) have the ability to differentiate into a variety of cell types and are a
potential source for epithelial tissue repair. Several studies have demonstrated their ability to repopulate the
gastrointestinal tract (GIT) in bone marrow transplanted patients or in animal models of gastrointestinal carcinogenesis
where they were the source of epithelial cancers. However, mechanism of MSC epithelial differentiation still remains unclear
and controversial with trans-differentiation or fusion events being evoked. This study aimed to investigate the ability of MSC
to acquire epithelial characteristics in the particular context of the gastrointestinal epithelium and to evaluate the role of cell
fusion in this process. In vitro coculture experiments were performed with three gastrointestinal epithelial cell lines and MSC
originating from two patients. After an 8 day coculture, MSC expressed epithelial markers. Use of a semi-permeable insert
did not reproduce this effect, suggesting importance of cell contacts. Tagged cells coculture or FISH on gender-mismatched
cells revealed clearly that epithelial differentiation resulted from cellular fusion events, while expression of mesenchymal
markers on fused cells decreased over time. In vivo cell xenograft in immunodeficient mice confirmed fusion of MSC with
gastrointestinal epithelial cells and self-renewal abilities of these fused cells. In conclusion, our results indicate that fusion
could be the predominant mechanism by which human MSC may acquire epithelial characteristics when in close contact
with epithelial cells from gastrointestinal origin . These results could contribute to a better understanding of the cellular and
molecular mechanisms allowing MSC engraftment into the GIT epithelium.
Citation: Ferrand J, Noe ¨l D, Lehours P, Prochazkova-Carlotti M, Chambonnier L, et al. (2011) Human Bone Marrow-Derived Stem Cells Acquire Epithelial
Characteristics through Fusion with Gastrointestinal Epithelial Cells. PLoS ONE 6(5): e19569. doi:10.1371/journal.pone.0019569
Editor: Marian Ludgate, Cardiff University, United Kingdom
Received November 15, 2010; Accepted April 12, 2011; Published May 5, 2011
Copyright:  2011 Ferrand et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was financially supported by the Institut de Recherche des Maladies de l’Appareil Digestif, the Institut Fe ´de ´ratif de Recherche 66 (http://
www.ifr66.u-bordeaux2.fr, Universite ´ Victor Segalen Bordeaux 2, France), the Association pour la Recherche contre le Cancer (http://www.arc-cancer.net/, ARC,
project number: 8412) and the Institut National du Cancer (http://www.e-cancer.fr, project number: 07/3D1616/IABC-23-12/NC-NG). J. Ferrand is the recipient of
fellowships from the French Ministry of Education, Research, and Technologies and ARC. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: francis.megraud@chu-bordeaux.fr
Introduction
Epithelial homeostasis, corresponding to a balance between
epithelial cell loss and epithelial cell production, has to be
maintained, particularly in the gastrointestinal tract (GIT) where
the epithelium needs to be renewed extremely rapidly to ensure its
function. The physiologic turnover of the epithelium is usually
considered to be initiated by local progenitor cells in each gland
which can give rise to different specialized epithelial cells [1].
However, mechanisms involved in tissue repair after damage
remain poorly understood. Cells originating from extra-gastroin-
testinal sites and particularly from the bone marrow may take part
in the repopulation of epithelial mucosa. Studies on gender-
mismatched human bone marrow transplants showed that donor-
derived cells can be retrieved in the epithelium of the
gastrointestinal tract (GIT) [2–6]. Tissue damage, especially in
grafts versus host disease or gastric ulcer, enhances engraftment of
bone marrow-derived cells (BMDC), revealing a close relationship
with the course of tissue regeneration [4–6]. The role of BMDC in
epithelium repair was confirmed in mouse GIT as they can
repopulate it in correlation with the level of damage after local
irradiation or gastritis induced by chronic infection with
Helicobacter felis [7–10].
From the different cell types constituting the stem cell
population of bone marrow, mesenchymal stem cells (MSC) have
been implicated in wound repair of numerous tissues [11]. MSC
are multipotent cells, able to migrate across tissues to differentiate
into a variety of cell types depending on the surrounding
microenvironment. Among them, the best studied and character-
ized cell types both in vivo and in vitro are adipocytes, chondrocytes,
osteoblasts and vascular smooth muscle cells [12]. In addition to
these mesenchymal lineages, MSC have been reported to give rise
to other cell types including epithelial cells [13]. However, due to
the lack of good in vitro models, mechanisms of MSC epithelial
differentiation and wound repair remain poorly understood and
the few data available are controversial.
First, MSC may acquire epithelial characteristics by repro-
grammation. In vitro studies showed that paracrine mechanisms,
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factors, allowed MSC differentiation in epithelial cells [14,15].
MSC preparations do not appear to be homogeneous due to the
lack of standardized protocols [16]. A study showed that MSC
subsets expressing cytokeratin 19 were involved in the establish-
ment of gastric epithelium after injection in mice [17]. These
findings were confirmed in vivo as BMDC could acquire an
epithelial phenotype in skin, liver and GIT without identification
of any fusion event [8,18,19].
However, very few studies concluded that MSC differentiation
occurs exclusively through a trans-differentiation mechanism, as
fusion events were not really evaluated and cannot be excluded
[20–22]. For example, indirect coculture with renal epithelial cells
leads to infrequent MSC epithelial differentiation, whereas direct
coculture leads to a greater percentage of differentiated cells [21].
The MSC adoption of different phenotypes may depend on the
nature of physical interaction as MSC direct contact cocultured
with keratinocytes expressed an epithelial phenotype in contrast to
observations for noncontact cocultures [23]. Thus, acquisition of
epithelial characteristics by MSC could be the consequence of
fusion with epithelial cells. In vitro studies showed that MSC can
fuse with small airway or lung epithelial cells thus leading to
differentiated epithelial cells [15,24]. Rizvi et al. demonstrated that
BMDC may adopt the phenotype of intestinal cells in vivo by fusion
with local epithelial cells after irradiation or in the context of
intestinal cancer development [10].
Besides their role in wound repair, MSC may take part in
carcinogenesis as accumulating data indicate that they can
transform into malignant cells [8,25,26]. Due to their mesodermal
origin, transformed MSC were shown to be at the origin of
mesenchymal cancers such as Ewing’s sarcoma and undifferenti-
ated sarcoma in aging mice [25,26]. The ability of MSC to
differentiate into cells of endodermal origin suggests that MSC
could be the source of other types of cancers. Concerning the GIT,
MSC were described to be at the origin of gastric carcinoma or
pre-neoplasic dysplasia in Barrett’s esophagus [8,27]. In addition,
the presence of MSC in the tumoral environment could also favor
cancer development by differentiation into tumor-associated
fibroblasts contributing to angiogenesis and metastasis formation
[28–30], although this role remains controversial [31–33].
In order to better understand the role of MSC in GIT
epithelium physiopathology, this study aimed to evaluate the
mechanisms by which human bone marrow-derived MSC
cultured with epithelial cells may acquire epithelial characteristics
in vitro. This may further allow a better understanding of the
mechanisms of MSC engraftment into the GIT epithelium and
their participation in gastrointestinal physiology and diseases.
Results
Characterization of MSC
After isolation from two different human donors who under-
went hip replacement for osteonecrosis, cultured BMDC exhibited
fibroblast-like cell morphology, typical phenotypes and possessed
self renewal properties. PM7 and PM24 cells were positive for
CD73, CD90, CD105 and negative for CD34, CD45, CD11b and
CD14 (data not shown). After chondrogenic induction, AGG,
Col2, Col10 and COMP mRNAs were increased compared to
non-induced MSC (Figure 1A). When cultured in an adipogenic
medium, expression of PPAR c, LPL and FABP4 mRNAs was
increased. In addition, differentiated cells displayed a positive
staining of cytoplasmic lipid droplets with oil red O (Figure 1B).
After 21 days of osteogenic differentiation, a slight increase of
Runx2 mRNA, which is a early marker of osteogenesis, was
observed. All the other osteoblastic markers tested (OC, AP,
Runx2 and Col1) were up-regulated. More importantly, secretion
of a mineralized matrix, as shown by positive alizarin red S
staining, was observed demonstrating differentiation of MSC
towards osteoblasts.(Figure 1C).
The two cell populations obtained, PM7 and PM24, fulfilled the
criteria proposed by the Mesenchymal and Tissue Stem Cell
Committee of the International Society for Cellular Therapy to
define MSC [34].
Human MSC may express epithelial markers after
coculture with gastrointestinal cell lines
In order to study the ability of MSC to differentiate into gastric
epithelial cells, GFP PM7 were cocultured with DsRED AGS
gastric epithelial cells at a ratio of 8:1 in culture plates (Figure 2).
The 8:1 ratio was chosen because of the difference of growth
kinetics between MSC (low growth) and epithelial cell lines (rapid
growth). After 8 days of coculture, cells expressing both eGFP and
DsRED were detected (Figure 2A–B, white arrows). The presence
of two or more nuclei was detected in most of these cells. As seen
in the previous experiments, these heterokaryons were probably
the consequence of plasma membrane fusion between the two cell
populations. In addition, these fused cells were positive for
epithelial cytokeratins, whereas MSC alone were negative
(Figure 2A). In order to confirm the epithelial phenotype of fused
cells, the expression of another specific epithelial marker, ESA,
was evaluated. ESA was expressed at the cell surface of epithelial
cells but not on the MSC (Figure 2B). eGFP and DsRED double
positive cells expressed ESA (Figure 2B, white arrows).
We confirmed by confocal microscopy and 3D reconstitution
that cells expressing eGFP, DsRED and ESA were single cells, as
shown by the 3 labellings on the same z-level (Figure 2C).
Similar experiments were performed by direct coculture of
eGFP PM7 with the DsRED transduced colon carcinoma cell line
HT-29. After coculture, eGFP and DsRED double positive cells
appeared, and these cells were positive for cytokeratins and ESA
(Figure S1).
The same results were obtained using PM24 MSC (data not
shown). We also verified that cell transduction was not responsible
for an increased capacity of cells to fuse. MSC and epithelial cells
were labelled green or red with membrane fluorescent dyes, PKH2
or CM-Dil compounds, respectively. PKH2-labelled MSC were
positive for ESA and CM-Dil after 8 days of coculture with CM-
Dil- labelled AGS, HT-29 or non-malignant gastric epithelial cells
HFE-145 confirming the previous results (data not shown).
Human MSC can acquire epithelial characteristics by a
mechanism of cellular fusion with gastrointestinal
epithelial cells
In order to confirm the MSC epithelial differentiation potential
and to assess the role of fusion, coculture of gender-mismatched
MSC and HFE-145 or AGS cells was performed, and phenotypes
were evaluated by pancytokeratin immunostaining combined with
FISH on sex chromosomes. Male PM7 and female AGS cells had
normal sex chromosome content (Figure 3A, C). HFE-145
epithelial cells displayed female specific chromosome content but
more than two X chromosomes were detected in many cells
(Figure 3B). Both HFE-145 and AGS cells expressed epithelial
pancytokeratin whereas MSC did not (Figure 3A–C).
An 8 day coculture led to the appearance of male-derived cells
which were positive for pancytokeratin (Figure 3D–E). Some of the
cells contained a single nucleus with abnormal content (ie one Y
chromosome and several X chromosomes) indicating that the
Epithelial Differentiation of Human MSC
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epithelial cell (Figure 3D–E). These results were observed both
with HFE-145 and AGS cells. Detailed analysis of cocultured PM7
with AGS cells revealed that some of the pancytokeratin positive
cells contained two nuclei, one with one X and one Y chromosome
(from a male MSC) and the other with two X chromosomes (from
a female AGS cell), indicating a fusion of membranes between a
male MSC and a female epithelial cell without fusion of the two
nuclei (Figure 3F). Finally, some cells expressed pancytokeratin
and contained only one nucleus with a male content (one X and
one Y chromosome), suggesting mitosis of fused multinucleated
cells leading to PM7-derived mononucleated daughter cells with
epithelial characteristics or PM7 epithelial differentiation without
fusion events (Figure 3G).
Fusion of human MSC and gastrointestinal cells leads to
an epithelial phenotype at a relatively important
frequency in vitro
To evaluate the frequency of MSC fusion with epithelial cells,
DsRED PM7 and eGFP HFE-145 cells were cocultured for 8
days, harvested, immunostained for ESA as an epithelial marker
and CD90 or CD105 as mesenchymal markers and analyzed by
flow cytometry (Figure 4A). After an 8 day coculture, fused cells
expressing both eGFP and DsRED appeared, while most of the
cells were eGFP positive due to the rapid growth of epithelial cells
compared to MSC (Figure 4A, right panel). The fused cells
population counted 1.360.2% among total cells corresponding to
7.761.3% of DsRED positive cells. Using DsRED AGS and eGFP
PM7 or DsRED HT-29 cells and eGFP PM24 MSC, 5.961.0%
Figure 1. Trilineage differentiation of MSC. Left panels show differentiation of PM7 and right panels show that of PM24. A/ Chondrogenic
differentiation was visualized by detection of AGG, Col2, Col10 and COMP mRNAs using RT-PCR. B/ Adipogenic differentiation was visualized by PPAR
c, LPL and FABP4 mRNAs using RT-PCR and Oil Red O staining of lipid droplets on day 0 (D0) and 21 (D21). C/ Osteogenic differentiation was
visualized by OC, AP, Runx2 and Col1 mRNAs using RT-PCR and Alizarin Red S staining on day 0 (D0) and 21 (D21). RT-PCR were performed on day
21 and results were compared to undifferentiated MSC on day 0 and normalized with RSP9 mRNAs. One representative experiment out of three is
presented. Original magnification 650. Scale bar, 10 mm.
doi:10.1371/journal.pone.0019569.g001
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respectively confirming the results previously obtained with PM7
and HFE-145 cells (Table 1).
Expression of ESA, CD90 and CD105 was then measured on
fused cells to determine their epithelial or mesenchymal phenotype
(Figure 4B). PM7 were negative for ESA staining but positive for
CD90 and CD105 expression, while HFE-145 cells were positive
for ESA and negative for CD90 and CD105 expression. Fused
cells expressed ESA (9960.0%) and heterogeneously CD90 and
CD105 (89.560.6% and 69.561.9%, respectively) after an 8 days
coculture. Expression of epithelial and mesenchymal markers was
then measured over time (Figure 4C). Expression of ESA remained
stable up to 17 days of coculture (100%60.0, p=1 versus day 8)
whereas expression of CD90 and CD105 significantly decreased
over time (21.564.8%, p,0.01 and 2.462.4%, p,0.01, respec-
tively, at day 17 versus day 8). These results suggest that fused cells
may loose their mesenchymal phenotype in favour of an epithelial
phenotype over time.
Fused cells observed by immunofluorescent staining appeared
larger than non fused cells (Figure 2). In order to quantify this
observation, forward scatter was measured by flow cytometry.
Over time, fused cells conserved a larger size compared to PM7
and HFE-145 cells (fused cells FSC-mean was 1.3560.10 times
higher than PM7 (p,0.01) and 1.8560.14 higher than HFE-145
(p,0.01) at day 17), confirming these findings.
Fusion appeared to be the predominant mechanism allowing
expression of epithelial markers by PM7 as only 15.360.6% of
ESA-positive DsRED PM7 were negative for eGFP expression at
day 8 and 6.861.0% at day 17. These cells possibly correspond to
MSC fused with non-transduced epithelial cells or trans-differen-
tiated cells or a loss of eGFP gene in a fused cell after mitosis event
(data not shown). In order to determine the ability of PM7 to
acquire epithelial characteristics without fusion events, eGFP PM7
and DsRED AGS cells were cocultured of both sides of a 0.4 mm-
cell culture insert. After indirect coculture for 8 days, 0.1760.05%
of PM7 expressed ESA staining versus 0.2360.05% when PM7
were cultured alone (p=0.23), strongly excluding the ability of
PM7 to trans-differentiate in epithelial cells (Table 1).
Fusion of MSC and epithelial cells can be observed in in
vivo system
AGS cells mixed freshly with MSC (AGS:MSC) at the same ratio
as that used in in vitro assays (1:8) were xenografted by subcutaneous
injection in NOG immunodeficient mice. Fifty days post-injection,
the mice were sacrificed and tumors were recovered for analysis.
Rare MSC-derived epithelial cells displaying a nucleus with one Y
chromosomeandexpressingcytokeratinswereobserved(Figure5A).
In addition, confocal microscopy revealed that some single cells had
nuclei with abnormal content which may have resulted from a
fusion event (nucleus with one Y and several X chromosomes) (data
not shown). Moreover, when cells from fresh tumors were
dissociated and cultured overnight on glass coverslips, fused cells
were observed by nuclei contents analysis by FISH (Figure 5B).
These results indicate that fusion events occurring in vivo led to
viable cells able to adhere and survive in vitro.
Discussion
In this study, we demonstrated for the first time that MSC can
acquire epithelial characteristics through a fusion mechanism with
gastric and intestinal epithelial cells. As primary gastrointestinal
epithelial cells are not available or cultivable in vitro over a long
period of time, two malignant (AGS and HT-29 cells) and one
non-malignant (HFE-145 cells) human gastrointestinal epithelial
cell lines were cocultured with two different samples of human
MSC. The same results were obtained in cocultures of MSC with
cancerous cells and non-cancerous cells as well as in an in vivo
model, reinforcing the hypothesis of the fusion process identified
by different techniques. Such evidence was lacking in previous
studies in which fusion events were not investigated in depth [20–
22]. Acquisition of an epithelial phenotype through cell fusion was
confirmed by the protein expression of two specific epithelial
markers not expressed by MSC alone, excluding a misleading gene
expression as is sometimes the case in neural differentiation [35].
This process involves a loss of mesenchymal markers expression
during time suggesting that the fused cells will evolve into epithelial
cells. We hypothesize that fusion events observed in vitro could be a
mechanism of engraftment leading to epithelial differentiation in
vivo. Engrafted MSC, undergoing stimuli from microenvironment,
may then be reprogrammed in vivo.
To date, it is well known that MSC are multipotent cells as they
can differentiate into different mesenchymal lineages and
participate to tissue physiopathology. In addition, MSC are
frequently considered as pluripotent cells since they have been
reported to give rise to cell types of neuroectodermal or
endodermal origins, e.g. endothelial, skeletal and cardiac muscle,
neural and epithelial cells; and hepatocytes [13]. The differenti-
ation is easily demonstrated by using culture conditions specific for
differentiation into adipocytes, chondrocytes, osteoblasts and
vascular smooth muscle cells [36], but is more difficult to
investigate when using in vitro coculture or in vivo systems to study
differentiation into hepatocytes, myoblasts or epithelial cells
[12,17,37,38]. The models in our study clearly show that one
mechanism of acquisition of epithelial characteristics by MSC is
fusion events. The presence of MSC-derived cells was also
confirmed by the use of FISH, lentiviral transduction and
chemical staining. In addition, the model of direct coculture used
in the present study could be considered to be closer in a way to
the physiological context compared to indirect coculture using
previously described cell culture insert systems, where trans-
differentiation events were observed [15,21]. In our study, cell
culture inserts did not allow trans-differentiation events, nor did
the use of growth factors as described by Paunescu et al. (data not
shown) [14]. In order to determine the fate of the fused cells
overtime, we considered it important to investigate this phenom-
enon in xenograft experiments in vivo using immunodeficient
recipient mice. Fused cells were found in vivo at the time of sacrifice
fifty days later and in vitro after culture of dissociated cells,
indicating that they are able to survive in vivo.
Fusion between BMDC and other tissue specific cells has
already been shown in vitro and in vivo with embryonic stem cells,
myoblasts, hepatocytes in the liver, Purkinje neurons, cardiac
Figure 2. Immunofluorescent staining of epithelial markers in MSC cocultured with gastric epithelial cells in vitro. eGFP MSC (PM7)
cells were cocultured with DsRED AGS epithelial cells for 8 days. A/ Immunostaining with cytokeratins (pCK) or B/ ESA primary antibodies were
revealed with AlexaFluor 647 labelled secondary antibodies (purple), and nuclei were stained with Hoechst 33342 compound (blue). C/ Three-
dimensional reconstruction of confocal laser microscopy imaging. Images shown represent maximum intensity projection on the x–y axis of the z-
stack and the projections of the orthogonal sections (1 and 2 dotted white lines) of the z-stack at the right side of each image. The first vertical panel
shows colored merge images with Hoechst, whereas black and white channels alone follow. White arrows show MSC fused with epithelial cells and
expressing cytokeratins. One representative experiment out of three is presented. Scale bar, 10 mm.
doi:10.1371/journal.pone.0019569.g002
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An exciting hypothesis is that in the context of gastrointestinal
epithelia repair, the fusion of MSC with epithelial cells could be of
major importance in initiating a rapid differentiation and an
effective integration in the GIT during Helicobacter infection,
gastric ulcer, esophagojejunostomy, graft versus host disease or
irradiation [1,7,8,10,27].
FISH experiments on gender-mismatched cocultured cells
showed that fusion also concerned nuclei. The observation of cells
displaying a single nucleus with a normal sexual chromosome
content and the absence of trans-differentiated cells suggest that a
fusion event may be followed by normal mitosis. Fusion has
already be shown to be responsible for nuclei reprogramming of
differentiated cells resulting in mitosis and selection for survival
[41]. Some authors even suggested that fusion events are an
obligatory step in the occurrence of cancer cells to acquire self
renewal and migratory properties [42,43]. In a mouse model,
complete units of dysplastic gastric epithelial glands were
reconstituted of MSC [8]. Interestingly a recent study showed
that the frequency of cellular fusion between MSC and cerebellar
neurons increased in the presence of TNF-a and/or IFN-c [44].
Considering our results, MSC fusion with gastrointestinal
epithelial cells may involve a reprogramming of the fused cells
rendering them more susceptible to transformation and leading to
the appearance of cancer stem cells in response to a chronic stress
like inflammation. Alternatively, MSC fusion with epithelial cells
could promote the cancerous process rather than initiate it. The
in vitro and in vivo models developed in the present study could
pave the way to a better understanding of the role of MSC-
derived epithelial cells in inflammation-related diseases and
cancers.
In conclusion, we demonstrated that MSC and gastrointestinal
epithelial cells can fuse when cultured in close contact both in vitro
and in vivo, conferring epithelial characteristics to MSC. The
models proposed will allow the study of the differentiation
mechanisms, as well as the key transcription factors involved, the
long term evolution of differentiated MSC and their potential role
in carcinogenesis.
Materials and Methods
Ethics Statement
Approval was obtained from the French Committee of Genetic
Enginneering (approval number 4608) and the local Central
Animal Facility Committee of the University of Bordeaux before
initiation of the study. All animal experiments were performed in
level 2 animal facilities of University Victor Segalen Bordeaux 2, in
accordance with institutional guidelines as determined by the
Central Animal Facility Committee of the University and in
conformity with the French Ministry of Agriculture Guidelines or
Animal Care.
Consent of MSC donors was written and approved by the
French Ministry of Research and the Languedoc Roussillon ethic
committee (approval number DC2009-1052).
Cell cultures
Human gastric carcinoma AGS cells (CRL-1739, ATCC,
Molsheim, France) were cultured in Dulbecco’s Modified Eagle
Medium - nutrient mixture F12 (DMEM-F12) and colon
carcinoma HT-29 cells (ACC 299, DSMZ collection, Braunsch-
weig, Germany) in McCoy’s 5A medium, supplemented with 10%
fetal calf serum (FCS) and antibiotics (100 U/ml penicillin and
100 mg/ml streptomycin, all from Invitrogen, Cergy Pontoise,
France). Human non-cancerous cell line HFE-145 was a kind gift
from D. Smoot (Howard University, Washington, USA) and was
cultured in the medium previously used for AGS cells [45].
MSC cultures were established from bone marrow samples of
donors suffering from osteonecrosis, a disease linked to
insufficient blood supply commonly associated with long-standing
corticosteroid use, undergoing hip replacement [46]. Although it
has been reported that the differentiation of mesenchymal stem
cells to adipocytes may be one of the mechanisms causing
increased intraosseous pressure and collapse of marrow sinusoids,
autologous BM-MSCs have been proposed as a novel treatment
option [47]. Cells were plated at a concentration of 5610
4 cells/
cm
2 in Minimal Essential Medium a (Invitrogen) supplemented
with 10% FCS, 1 ng/ml basic fibroblast growth factor (bFGF;
R&D Systems, Lille, France) and antibiotics. At subconfluence,
cells were harvested and plated at 1 000 cells/cm
2. Samples
from two donors, an 82 year old man and a 66 year old woman,
called PM7 and PM24 respectively, were used between passages
3a n d9 .
MSC characterization
Cell surface antigen expression of CD11b, CD34, CD45
(Beckman Coulter, Villepinte, France), CD14 (eBiosciences, San
Diego, CA, USA), CD73, CD90 and CD105 (BD Biosciences, Le
Pont de Claix, France) was measured by flow cytometry.
For chondrogenic differentiation, 2.5610
5 cells were centrifu-
gated at 600 g for 5 min. The resulting pellets were cultured in
DMEM supplemented with 0.1 mM dexamethasone, 0.17 mM
ascorbate-2-phosphate, 1% insulin-transferrin-sodium selenite
supplement (all from Sigma, l’Isle d’Abeau, France) and 10 ng/
ml of recombinant Transforming Growth Factor b3 (R&D
Systems).
For adipogenic differentiation, cells were plated at a density of
8610
3 cells/cm
2 and cultured in DMEM containing 5% FCS
(Invitrogen), 1 mM dexamethasone, 50 mM isobutyl-methylxan-
thine and 60 mM indomethacin (all from Sigma).
Osteogenesis was induced by culture at low density (2.5610
3
cells/cm
2) in DMEM with 10% FCS, 10 mM b-glycerophosphate,
0.1 mM dexamethasone and 0.05 mM ascorbic acid (all from
Sigma).
Media were changed three times a week. Differentiations were
assessed on day 21 by real-time reverse transcription PCR (RT-
qPCR) on extracted mRNAs, by visualization of lipid droplets
after oil red O staining for adipogenesis and by visualization of
matrix calcification after Alizarin red S staining for osteogenesis.
Figure 3. FISH analysis of MSC and epithelial gastric cell line cocultures. eGFP male MSC (PM7) cells were cultured with DsRED female
epithelial AGS or HFE-145 cells for 8 days and fixed. FISH (SpectrumGreen-Y chromosome and SpectrumOrange-X chromosome) was performed and
pancytokeratin primary antibodies were revealed with AlexaFluor 647 labelled secondary antibodies (purple), and nuclei were stained with Hoechst
33342 compound (blue). The first vertical panel shows colored merge images with Hoechst, whereas black and white channels alone follow. Green
arrows show Y chromosomes and red arrows X chromosomes. A–C/ Male PM7 expressed one Y chromosome and one X chromosome whereas
female AGS or HFE-145 cells expressed only X chromosomes and cytokeratins. D–E/ In PM7/HFE-145 or AGS cocultured cells: example of one cell
expressing cytokeratins and possessing a Y chromosome corresponding to a MSC-derived cell. In PM7/AGS cocultured cells, examples of one cell F/
expressing cytokeratins and harboring one male and one female nuclei or G/ expressing cytokeratins and harboring one nucleus with one Y
chomosome and one X chromosome. One representative experiment out of three is presented. Scale bar, 10 mm.
doi:10.1371/journal.pone.0019569.g003
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indicated times, harvested, stained with anti-ESA antibodies, detected by Alexa-647 labelled secondary antibodies and analyzed by flow cytometry.
A/ DsRED and eGFP expression of PM7, HFE-145 and cocultured cells was analyzed at day 9. Coculture of DsRED PM7 and eGFP HFE-145 cells led to
Epithelial Differentiation of Human MSC
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For chondrogenesis, micropellets were washed in PBS and
mechanically dissociated. For adipogenis and osteogenis, cells were
rinsed with PBS and the lysis buffer was added. Total RNA was
extracted using the RNeasy Kit according to the manufacturer’s
recommendations (Qiagen S.A., Courtaboeuf, France). Chondro-
genic differentiation was visualized by detection of aggregan (AGG),
collagen type II (Col2), collagen type X (Col10) and cartilage
oligomeric matrix protein (COMP) mRNAs; adipogenic differen-
tiation by detection of peroxisome proliferator-activated receptor c
(PPAR c), lipoprotein lipase (LPL) and fatty acid binding protein 4
(FABP4) mRNAs; and osteogenic differentiation by osteocalcin
(OC), alkaline phosphatase (AP), Runx2 and collagen type I (Col1)
mRNAs (personal data). RT-PCR was performed on day 21 and
results were compared to undifferentiated MSC on day 0.
Cellular labelling
The eGFP encoding TMEW and the DsRED encoding
TMDW lentiviral vectors were kindly provided by F. Moreau
Gaudry (Vectorology Platform, Universite ´ Victor Segalen Bordeaux
2, France). Gastrointestinal epithelial cells and MSC were
transduced respectively with lentiviral particles containing the
vectors encoding DsRED and eGFP at multiplicities of infection
ranging from 1 to 20. Twenty-four hours after transduction,
transduction efficiency was measured by flow cytometry and cell
samples with 30% positive cells were sorted to obtain a
homogeneous population.
For staining with fluorescent chemical compounds, the PKH2
Green Fluorescent Cell Linker Kit (Sigma) and CM-Dil cell
labelling solution (Vybrant, Invitrogen) were used according to the
manufacturer’s recommendations. Briefly, cells were harvested
and resuspended in 1 ml of labelling solutions (PKH2 or CM-Dil)
for the indicated time in the manufacturer’s instructions. Cells
were washed three times in culture medium before use.
Coculture experiments and fluorescent staining
Coculture experiments of MSC and epithelial cells were
performed at a ratio of 8:1 (20 000 MSC:2 500 epithelial cells)
in 24-well culture plates. Cells were cultured on 12 mm glass
coverslips for immunofluorescent stainings. A 0.4 mm cell culture
insert system was used for the indirect coculture assay (BD
Biosciences). 20 000 MSC and 2 500 epithelial cells were seeded
on the bottom chamber or on the top chamber, respectively.
Coculture experiments were performed for indicated times in
MSC medium without bFGF changed three times a week.
For immunofluorescent staining, cells were washed with PBS to
remove cellular debris, then fixed with 3% paraformaldehyde
prepared in cytoskeletal buffer for 10 min and processed as
previously described [48]. Primary and secondary antibodies were
diluted at the following concentrations: 1:100 for mouse anti-
Epithelial Specific Antigen (ESA) antibodies (StemCell Technolo-
gies, Grenoble, France), 1:100 for mouse anti-pancytokeratin
antibodies (Ozyme, St Quentin Yvelines, France), 1:500 for Alexa-
647 labelled goat anti-mouse antibodies (Molecular Probes, Invitro-
gen) and Hoechst 33342 (1 mg/ml) compound was used as nuclear
counterstain(Molecular Probes,Invitrogen).Coverslipswere washed
in water and mounted on microscope slides with Fluoromount
mounting medium (Clinisciences SA, Montrouge, France).
For Fluorescence In Situ Hybridization (FISH), cells were fixed in
3.7% formaldehyde solution in PBS for 10 min, washed in PBS and
dehydrated in ethanol series before hybridization. FISH experi-
ments with the alpha satellite centromeric region of the X
chromosome and the satellite III (Yq12) region of the Y
chromosome were performed according to manufacturer’s instruc-
tions (Abbott Molecular, Rungis, France). Coverslips were washed
in PBS, and immunofluorescently stained as previously described.
For flow cytometry analysis, cells were incubated at room
temperature with mouse anti-ESA antibodies, rat anti-CD90 or rat
anti-CD105 in PBS (1:100) for 20 min, washed and incubated
with Alexa-647 labelled anti-mouse or anti-rat secondary anti-
bodies in PBS (1:200) for 15 min. Cells were resuspended in PBS
before being analyzed in a BD FACSCanto II flow cytometer
using FACSDiva software (BD Biosciences).
Mouse in vivo xenografts
Immunodeficient non obese diabetous/Shi-severe combined
immunodeficiency/interleukin-2Rc
null (NOG) mice were in-
Table 1. Quantification of fusion events between MSC and epithelial cells by flow cytometry analysis.
Direct coculture Percentage of eGFP+, DsRED+ and ESA+ cells
eGFP or DsRED PM7 alone 0.060.0%
DsRED PM7/eGFP HFE-145 7.761.3%
eGFP PM7/DsRED AGS 5.961.0%
eGFP PM7/DsRED HT-29 7.163.7%
Indirect coculture Percentage of ESA+ MSC-derived cells
PM7 alone 0.2360.05%
PM7/AGS 0.1760.05%
For direct coculture, eGFP or DsRED MSC (PM7) cells were cultured with epithelial (DsRED AGS, eGFP HFE-145 and DsRED HT-29) cells for 8 days, harvested, stained with
anti-ESA antibodies, detected by Alexa-647 labelled secondary antibodies. For indirect coculture, PM7 and epithelial cells (AGS) were separated bya0 . 4mm cell culture
insert and processed as for direct coculture. Cells were then analyzed by flow cytometry. Results represent the mean 6 SD of one experiment with three replicates
representative of at least three different experiments.
doi:10.1371/journal.pone.0019569.t001
the appearance of fused cells (1.3%60.2 of total cells). B/ Fused cells expression of epithelial (ESA) and mesenchymal (CD90 and CD105) markers was
measured at day 9. Fused cells expressed ESA (99%60.0 of positive cells); CD90 (89.5%60.6) and CD105 (69.5%61.9). C/ Expression of epithelial and
mesenchymal markers was assessed at day 9, 15 and 17. Expression of ESA was stable whereas expression of mesenchymal markers decreased over
time. Results represent the mean 6 SD of one experiment with three replicates representative of at least three different experiments.
doi:10.1371/journal.pone.0019569.g004
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and 375 000 cells, respectively) resuspended in 200 mlo f7m g /
ml Matrigel (BD Biosciences) in ice cold PBS. Mice were
anesthetized with 3% isofluran (Belamont, Boulogne Bill-
ancourt, France) before subcutaneous injection into the right
flank. When tumor sizes reached 100 mm
2, mice were
sacrificed by cervical dislocation and tumors immediately
harvested, embedded in Optimal Cutting Temperature
(OCT) compound (Sakura, Labonord, Villeneuve d’Asq,
France) and snap frozen in cooled isopentane with liquid
nitrogen. Tissues were stored at 280uC before being cut into
7 mm thick serial sections on a cryostat (Leica Microsystems,
Nanterre, France). Tissue sections mounted on glass slides were
processed as previously described.
Some tumor samples were cultured on glass coverslips after
dissociation. Briefly, after mechanical mincing, samples were
dissociated by incubation with 0.1% collagenase and 0.0125%
hyaluronidase in PBS (all from Sigma) for 45 min at 37uC and
filtered through a 70 mm cell strainer. Erythrocytes were lysed at
4uC for 10 min with 170 mM NH4Cl, 2 mM KHCO3 and
0.1 mM ethylene-diamine-tetra-acetic acid (EDTA) before plating
the cells on glass coverslips. After an overnight culture, cells were
fixed with 3.7% formaldehyde and processed for stainings.
Microscopy analysis
Cells were analyzed using a Eclipse 50i epi-fluorescence
microscope (Nikon, Champigny sur Marne, France) equipped
with the Nis Element acquisition software and a 640 (numerical
aperture, 1.3) oil immersion objective or a DMI6000 confocal
microscope (Leica Microsystems, Rueil Malmaison, France)
equipped with the LEICA acquisition software and a 663
(numerical aperture, 1.4) oil immersion objective. Z-stack
acquisitions were performed by 0.5 mm slicing.
Statistical analysis
Quantification values represent the means of one experiment
with three replicates representative of at least three different
experiments in each 6 standard deviation (SD). For immunoflu-
orescent microscopy analysis, a minimum of 500 cells were
analyzed and one representative experiment out of three is
presented. For flow cytometry analysis, 100,000 cells were
analyzed for each condition to determine the mean percentage
of positive cells for studied parameters. Significance was
determined using the Student’s t-test.
Supporting Information
Figure S1 Immunofluorescent staining of epithelial
markers in MSC cocultured with colon epithelial cells
in vitro. eGFP MSC (PM7) cells were cocultured with DsRED
HT-29 epithelial cells for 8 days. A/ Immunostaining with
cytokeratins (pCK) or B/ ESA primary antibodies were revealed
with AlexaFluor 647 labelled secondary antibodies (purple), and
nuclei were stained with Hoechst 33342 compound (blue). The
first vertical panel shows colored merge images with Hoechst,
whereas black and white channels alone follow. White arrows
show MSC fused with epithelial cells and expressing cytokeratins.
One representative experiment out of three is presented. Scale bar,
10 mm.
(TIF)
Figure 5. FISH analysis of chromosome content of tumor cells resulting from human MSC and AGS cell xenografts in
immunodeficient mice. A/ Male MSC (PM7) and female AGS cells were injected subcutaneously in NOG mice. After 50 days, mice were sacrificed
and tumors resulting from transplanted cells were processed and analyzed by immunofluorescence and FISH (SpectrumGreen-Y chromosome and
SpectrumOrange-X chromosome). Cytokeratins were stained with primary antibodies revealed by secondary AlexaFluor 647 labelled antibodies
(purple), and nuclei were stained with Hoechst 33342 compound (blue). The first vertical panel shows colored merge images, whereas black and
white channels alone follow. Red and green arrows show chromosomes of one male-derived cell expressing cytokeratins. B/ Cells from tumors were
dissociated and cultured in vitro for 24 h. Cells were processed as in A. Male derived cells expressing cytokeratins possess abnormal chromosome
content but are viable and adhere to coverslips. White bar, 10 mm.
doi:10.1371/journal.pone.0019569.g005
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